142 related articles for article (PubMed ID: 9918519)
1. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
Circulation; 1999 Jan; 99(3):344-7. PubMed ID: 9918519
[TBL] [Abstract][Full Text] [Related]
2. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
J Am Coll Cardiol; 1999 Oct; 34(4):1123-8. PubMed ID: 10520801
[TBL] [Abstract][Full Text] [Related]
3. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.
Flores-Ramirez R; Lakkis NM; Middleton KJ; Killip D; Spencer WH; Nagueh SF
J Am Coll Cardiol; 2001 Jan; 37(1):208-14. PubMed ID: 11153740
[TBL] [Abstract][Full Text] [Related]
4. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy.
Sitges M; Shiota T; Lever HM; Qin JX; Bauer F; Drinko JK; Agler DA; Martin MG; Greenberg NL; Smedira NG; Lytle BW; Tuzcu EM; Garcia MJ; Thomas JD
Am J Cardiol; 2003 Apr; 91(7):817-21. PubMed ID: 12667567
[TBL] [Abstract][Full Text] [Related]
5. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Honek T
Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
[TBL] [Abstract][Full Text] [Related]
6. [Doppler echocardiographic evaluation of left ventricular diastolic function in patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation in acute and long-term follow up].
Wojtarowicz A; Kornacewicz-Jach Z; Kaźmierczak J; Szamlewski P; Gil R; Lewandowski M
Pol Merkur Lekarski; 2002 Jul; 13(73):25-8. PubMed ID: 12362500
[TBL] [Abstract][Full Text] [Related]
7. Acute effect of nonsurgical septal reduction therapy on regional left ventricular asynchrony in patients with hypertrophic obstructive cardiomyopathy.
Park TH; Lakkis NM; Middleton KJ; Franklin J; Zoghbi WA; Quiñones MA; Spencer WH; Nagueh SF
Circulation; 2002 Jul; 106(4):412-5. PubMed ID: 12135938
[TBL] [Abstract][Full Text] [Related]
8. Effects of septal myectomy on left ventricular diastolic function and left atrial volume in patients with hypertrophic cardiomyopathy.
Tower-Rader A; Furiasse N; Puthumana JJ; Kruse J; Li Z; Andrei AC; Rigolin V; Bonow RO; McCarthy PM; Choudhury L
Am J Cardiol; 2014 Nov; 114(10):1568-72. PubMed ID: 25260948
[TBL] [Abstract][Full Text] [Related]
9. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy.
Henein MY; O'Sullivan CA; Ramzy IS; Sigwart U; Gibson DG
J Am Coll Cardiol; 1999 Oct; 34(4):1117-22. PubMed ID: 10520800
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
[TBL] [Abstract][Full Text] [Related]
11. The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy.
Dimitrow PP; Grodecki J; Bacior B; Dudek D; Legutko J; Jaszcz KK; Dubiel JS
Pacing Clin Electrophysiol; 2000 Sep; 23(9):1324-9. PubMed ID: 11025886
[TBL] [Abstract][Full Text] [Related]
12. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
Nagueh SF; Lakkis NM; He ZX; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Roberts R; Verani MS; Kleiman NS; Spencer WH
J Am Coll Cardiol; 1998 Jul; 32(1):225-9. PubMed ID: 9669274
[TBL] [Abstract][Full Text] [Related]
13. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
[TBL] [Abstract][Full Text] [Related]
14. Biphasic left ventricular outflow and its mechanism in hypertrophic obstructive cardiomyopathy.
Conklin HM; Huang X; Davies CH; Sahn DJ; Shively BK
J Am Soc Echocardiogr; 2004 Apr; 17(4):375-83. PubMed ID: 15044873
[TBL] [Abstract][Full Text] [Related]
15. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.
Chang SM; Nagueh SF; Spencer WH; Lakkis NM
J Am Coll Cardiol; 2003 Jul; 42(2):296-300. PubMed ID: 12875767
[TBL] [Abstract][Full Text] [Related]
16. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures.
Nielsen CD; Killip D; Spencer WH
Clin Cardiol; 2003 Jun; 26(6):275-9. PubMed ID: 12839045
[TBL] [Abstract][Full Text] [Related]
17. Mid-systolic drop in left ventricular ejection velocity in obstructive hypertrophic cardiomyopathy--the lobster claw abnormality.
Sherrid MV; Gunsburg DZ; Pearle G
J Am Soc Echocardiogr; 1997 Sep; 10(7):707-12. PubMed ID: 9339420
[TBL] [Abstract][Full Text] [Related]
18. Dyssynchronization reduces dynamic obstruction without affecting systolic function in patients with hypertrophic obstructive cardiomyopathy: a pilot study.
Giraldeau G; Duchateau N; Bijnens B; Gabrielli L; Penela D; Evertz R; Mont L; Brugada J; Berruezo A; Sitges M
Int J Cardiovasc Imaging; 2016 Aug; 32(8):1179-88. PubMed ID: 27146905
[TBL] [Abstract][Full Text] [Related]
19. Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy.
Kondo I; Mizushige K; Nozaki S; Iwado Y; Masugata H; Kohno M; Matsuo H
Cardiovasc Drugs Ther; 2001 Sep; 15(5):459-65. PubMed ID: 11855665
[TBL] [Abstract][Full Text] [Related]
20. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Jassal DS; Neilan TG; Fifer MA; Palacios IF; Lowry PA; Vlahakes GJ; Picard MH; Yoerger DM
Eur Heart J; 2006 Aug; 27(15):1805-10. PubMed ID: 16774986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
